The combined vaccine elicited higher immune response against SARS-CoV-2.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
The BQ.1.1 and XBB SARS-CoV-2 subvariants evade monoclonal antibodies but not the antiviral drugs remdesivir, molnupiravir, and Paxlovid.
Patients hospitalized with severe COVID-19 breathing problems are less likely to need intubation if they lie face down, but the position's effect on death or other outcomes is inconclusive.
Amid rising cases, eased restrictions come with intensified efforts to vaccinate seniors.
A total of 22,006 adverse outcomes occurred, mostly in patients who took metformin before COVID-19 diagnosis (37.1%), while 19.5% each had used insulin or DPP-4is.
Swedish study shows ICU patients most likely to experience long COVID.
The bivalent booster marshaled a robust antibody response against the Omicron BA.4/BA.5 subvariants but not against the more recently emerged variants.
Minorities were underrepresented in both COVID-19 clinical treatment trials and in disease prevention trials.
Rebound was uncommon after use of the oral antivirals Paxlovid and molnupiravir to lower the risk of severe outcomes.
Protection was 35% among those vaccinated before contracting COVID-19.
Amid rising flu activity causing decade-high hospitalization rates, COVID-19 markers are also climbing.
